Holly S Vitense

7496409, Feb 24, 2009

Mar 29, 2006

11/392065

Saul E. Greenhut - Aurora CO, US
Robert W. Stadler - Shoreview MN, US
Holly S. Vitense - Maple Grove MN, US

Medtronic, Inc. - Minneapolis MN

A61N 1/00

607116

An implantable medical device system and method are provided for monitoring the quality of signals sensed by a subcutaneously implanted device using subcutaneous electrodes. In one embodiment, the method includes selecting one or more sensing vectors; sensing signals from selected sensing vectors, determining a signal quality metric in response to a sensed signal, comparing the signal quality metric to a predetermined threshold, and generating a loss of signal quality response in response to the signal quality crossing the threshold.

20060017576, Jan 26, 2006

Oct 29, 2004

10/977242

Paul Gordon - St. Louis Park MN, US
Javaid Masoud - Shoreview MN, US
James Ball - St. Paul MN, US
Holly Vitense - Maple Grove MN, US
James Willenbring - St. Paul MN, US
Sean McAdams - Minneapolis MN, US
Dean Hooper - Oak Grove MN, US

G08B 23/00

340573100, 600300000

An alert system for alerting a clinician to an occurrence of an event detected by an implantable medical device includes a monitor and a patient management network. The implantable medical device includes a means for detecting the occurrence of the event and initiating a wireless transmission of data related to the event. The monitor is configured to receive the wireless transmission of data and transfer the data. The patient management network is configured to receive the data and store the data on a data storage device. The patient management network includes a web presentation service for creating a website from the data stored on the data storage device, the website configured to alert the clinician to the occurrence of the event.

20080103530, May 1, 2008

Oct 31, 2006

11/554825

Holly S. Vitense - Maple Grove MN, US
Li Wang - Hong Kong, CN
Denise Dirnberger - Blaine MN, US
Melissa M. Rhodes - Columbia Heights MN, US
Douglas A. Hettrick - Andover MN, US
Shantanu Sarkar - St. Paul MN, US

A61N 1/00

607 2

The capability to suspend a patient alert relating to a monitored physiologic parameters addresses a need to selectively shut off a patient-alert signal or signals during the time a patient is being treated for an excursion in the parameter. Of course, in general a signal call attention to a patient's a potentially deleterious status or condition for which they should seek medical attention. Once a chronically-implanted monitoring device has detected or provided information about the parameter relative to a desired value, trend, or range and a clinician has been notified and intervened the alert signal is temporarily disabled for a predetermined period. That is, once the notification occurs and alert has served its purpose, the alert mechanism is selectively deactivated while the patient ostensibly begins to gradually correct the monitored physiologic parameter under a caregiver's direction and control. After which time, the alert will reactivate.

20100114206, May 6, 2010

Oct 31, 2008

12/263279

William F. Kaemmerer - Edina MN, US
Elizabeth A. Ellingson - Blaine MN, US
Mark L. Brown - North Oaks MN, US
Bruce D. Gunderson - Plymouth MN, US
Holly Vitense - Maple Grove MN, US

A61N 1/39

607 5

A method and system for diagnosing a medical condition, alerting a patient that a therapy is impending, and allowing the patient to override or modify the impending therapy are provided. The system may include an implantable medical device (“IMD”) and a patient interface device. The IMD may sense a physiological parameter within a patient, determine whether the physiological parameter qualifies for therapy based on a therapy criteria, and alert the patient via the patient interface device that therapy is impending if the physiological parameter qualifies for therapy. The patient may be given an opportunity to respond to the alert with the patient interface device and send an therapy modification indication if the therapy is not needed or wanted. The IMD may wait a predetermined period of time for the patient response and deliver the therapy if the patient response is not transmitted before expiration of the predetermined period of time or withhold the therapy if the patient overrides the delivery of the therapy within the predetermined period of time. The IMD may adjust one or more operational settings applied during its operation in response to the activity of the system. The patient interface device may be configured to avoid accidental override or modification of the delivery of the therapy.

20120303085, Nov 29, 2012

Aug 9, 2012

13/570858

Holly S. Vitense - Maple Grove MN, US
Li Wang - Hong Kong, CN
Denise Dirnberger - Blaine MN, US
Melissa M. Rhodes - Columbia Heights MN, US
Douglas A. Hettrick - Andover MN, US
Shantanu Sarkar - St. Paul MN, US

Medtronic, Inc. - Minneapolis MN

A61N 1/365

607 28

The capability to suspend a patient alert relating to a monitored physiologic parameters addresses a need to selectively shut off a patient-alert signal or signals during the time a patient is being treated for an excursion in the parameter. Of course, in general a signal call attention to a patient's a potentially deleterious status or condition for which they should seek medical attention. Once a chronically-implanted monitoring device has detected or provided information about the parameter relative to a desired value, trend, or range and a clinician has been notified and intervened the alert signal is temporarily disabled for a predetermined period. That is, once the notification occurs and alert has served its purpose, the alert mechanism is selectively deactivated while the patient ostensibly begins to gradually correct the monitored physiologic parameter under a caregiver's direction and control. After which time, the alert will reactivate.

20220193419, Jun 23, 2022

Mar 9, 2022

17/690723

- Minneapolis MN, US
Douglas A. Hettrick - Andover MN, US
Amul Y. Desai - Plymouth MN, US
Randolph M. Biallas - Louisville CO, US
Holly S. Vitense - Maple Grove MN, US
Jodi L. Redemske - Maple Grove MN, US

A61N 1/365
A61B 5/024
A61B 5/0245
A61B 5/00
A61B 5/0537
G16H 50/20
G16H 50/30
A61B 5/349
A61B 5/0538
A61N 1/362
A61M 5/142
A61M 5/172
A61N 1/39

Techniques for using multiple physiological parameters to provide an early warning for worsening heart failure are described. A system is provided that monitors a multiple diagnostic parameters indicative of worsening heart failure. The parameters preferably include are least one parameter acquired from an implanted device, such as intrathoracic impedance. The system device derives an index of the likelihood of worsening heart failure based upon the parameters using a Bayesian approach and displays the resultant index for review by a physician.

20180126172, May 10, 2018

Dec 21, 2017

15/850024

- Minneapolis MN, US
Douglas A. Hettrick - Andover MN, US
Amul Y. Desai - Plymouth MN, US
Randolph M. Biallas - Louisville CO, US
Holly S. Vitense - Maple Grove MN, US
Jodi L. Redemske - Fridley MN, US

A61N 1/365
A61M 5/172
A61M 5/142
A61N 1/39

Techniques for using multiple physiological parameters to provide an early warning for worsening heart failure are described. A system is provided that monitors a multiple diagnostic parameters indicative of worsening heart failure. The parameters preferably include are least one parameter acquired from an implanted device, such as intrathoracic impedance. The system device derives an index of the likelihood of worsening heart failure based upon the parameters using a Bayesian approach and displays the resultant index for review by a physician.

20160361026, Dec 15, 2016

Mar 29, 2011

13/391376

Shantanu Sarkar - Minnesota MN, US
Douglas A. Hettrick - Andover MN, US
Amul Y. Desai - Plymouth MN, US
Randolph M. Biallas - Littleton CO, US
Holly S. Vitense - Maple Grove MN, US
Jodi L. Redemske - Fridley MN, US

Medtronic, Inc. - Minneapolis MN

A61B 5/00
A61B 5/0245
G06F 19/00
A61N 1/365
A61N 1/362
A61B 5/024
A61B 5/053

Techniques for using multiple physiological parameters to provide an early warning for worsening heart failure are described. A system is provided that monitors a multiple diagnostic parameters indicative of worsening heart failure. The parameters preferably include are least one parameter acquired from an implanted device, such as intrathoracic impedance. The system device derives an index of the likelihood of worsening heart failure based upon the parameters using a Bayesian approach and displays the resultant index for review by a physician.